- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 699-713 of
973 results
1019 Exhibit: Ex 1019 Email from Merck to Joinder Petitioners Regarding Silent Un...
Document
IPR2020-01072, No. 1019 Exhibit - Ex 1019 Email from Merck to Joinder Petitioners Regarding Silent Understudy Conditions (P.T.A.B. Jul. 29, 2020)
|
|
Cite Document
1020 Exhibit: Ex 1020 Complaint, Merck Sharp Dohme Corp v Dr Reddys Laborator...
Document
IPR2020-01072, No. 1020 Exhibit - Ex 1020 Complaint, Merck Sharp Dohme Corp v Dr Reddys Laboratories, Inc et al, No 20 cv 00847 RGA, ECF 1 D Del June 24, 2020 (P.T.A.B. Jul. 29, 2020)
|
|
Cite Document
2037 Exhibit: EX2037 20200702 Email from Merck to Joinder Petitioners
Document
IPR2020-01072, No. 2037 Exhibit - EX2037 20200702 Email from Merck to Joinder Petitioners (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2035 Exhibit: EX2035 20200702 Email regarding Chorghade Deposition Date
Document
IPR2020-01072, No. 2035 Exhibit - EX2035 20200702 Email regarding Chorghade Deposition Date (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2029 Exhibit: EX2029 20200701 Email from Joinder Petitioners
Document
IPR2020-01072, No. 2029 Exhibit - EX2029 20200701 Email from Joinder Petitioners (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2039 Exhibit: EX2039 Teva Complaint
Document
IPR2020-01072, No. 2039-2 Exhibit - EX2039 Teva Complaint (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
1005 Exhibit: Ex 1005 Brittain, Polymorphism in Pharmaceutical Solids
Document
IPR2020-01072, No. 1005 Exhibit - Ex 1005 Brittain, Polymorphism in Pharmaceutical Solids (P.T.A.B. Jun. 12, 2020)
|
|
Cite Document
1016 Exhibit: Ex 1016 Brown et al, Chemistry The Central Science, 8th Revised Edi...
Document
IPR2020-01072, No. 1016 Exhibit - Ex 1016 Brown et al, Chemistry The Central Science, 8th Revised Edition 615 618 2002 (P.T.A.B. Jun. 12, 2020)
|
|
Cite Document
1009 Exhibit: Ex 1009 Orange Book Entry for Januvia
Document
IPR2020-01072, No. 1009 Exhibit - Ex 1009 Orange Book Entry for Januvia (P.T.A.B. Jun. 12, 2020)
|
|
Cite Document
2036 Exhibit: EX2036 20200702 Email from Mylan Reserving Rights
Document
IPR2020-01072, No. 2036 Exhibit - EX2036 20200702 Email from Mylan Reserving Rights (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2030 Exhibit: EX2030 Excerpt of January 29, 2015 Trial Transcript with Dr Chyalls T...
Document
IPR2020-01072, No. 2030 Exhibit - EX2030 Excerpt of January 29, 2015 Trial Transcript with Dr Chyalls Testimony (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
1010 Exhibit: Ex 1010 Complete copy of the prosecution history of the 708 patent a...
Document
IPR2020-01072, No. 1010 Exhibit - Ex 1010 Complete copy of the prosecution history of the 708 patent as available for download from the USPTO website (P.T.A.B. Jun. 12, 2020)
|
|
Cite Document
2031 Exhibit: EX2031 Excerpt of Dr Chyalls third declaration
Document
IPR2020-01072, No. 2031 Exhibit - EX2031 Excerpt of Dr Chyalls third declaration (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2034 Exhibit: EX2034 Sun Pharm Indus Ltd Corporate Action Report
Document
IPR2020-01072, No. 2034 Exhibit - EX2034 Sun Pharm Indus Ltd Corporate Action Report (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
2027 Exhibit: EX2027 20200629 Email regarding Mylan Opposition to Schedule Ch...
Document
IPR2020-01072, No. 2027 Exhibit - EX2027 20200629 Email regarding Mylan Opposition to Schedule Change (P.T.A.B. Jul. 10, 2020)
|
|
Cite Document
